Presentation and investigations
Pt | Age | Previous therapy for idiopathic thrombocytopenic purpura | Igs and lymphocytes pre-rituximab | History of infections pre-rituximab | Date (and cycles) of rituximab | Igs and lymphocytes† | History of infections post-rituximab | |||
1 | 43 |
|
|
|
|
|
|
|
| |
|
|
| ||||||||
2 | NA |
|
|
|
|
|
|
|
|
|
|
|
|
|